跳至主要内容
临床试验/NCT02493231
NCT02493231Unknown4 期

Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia

Hallym University Kangnam Sacred Heart Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
duration of analgesic free

研究概览

简要总结

Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient who scheduled laparoscopic cholecystectomy under general anesthesia
  • American Society of Anesthesiologist(ASA) class I or II
  • adult patient (age 20 - 65)

排除标准

  • patient who has liver disease
  • patient who has kidney disease
  • patient who has diabetes mellitus(DM) or heart disease
  • patient who takes opioid or beta-blocker
  • patient who has airway disease
  • patient who has allergy with the drug

研究组 & 干预措施

Nefopam

Active Comparator

The generic name is 'ACUPAN'. It is infused during operation. A induction dose is 0.3mg/Kg. A maintenance dose is 65 mcg/kg/hr

干预措施: Nefopam (Drug)

Ketamine

Active Comparator

It is infused during operation. A induction dose is 0.3 mg/Kg. A maintenance dose is 3 mcg/kg/hr

干预措施: Ketamine (Drug)

Saline

Placebo Comparator

It is infused during operation. A induction volume is 3mL A maintenance dose is 10mL/hr

干预措施: Saline (Drug)

结局指标

主要结局

duration of analgesic free

时间窗: During 1 hour at PACU

analgesic requirement

时间窗: During 1 hour at PACU

次要结局

  • analgesic requirement(During 8 hours after arriving at ward)
  • Pain on the VAS scale(During 1 hour at PACU)

研究者

发起方
Hallym University Kangnam Sacred Heart Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lee Mi Hyeon

assistant professor

Hallym University Kangnam Sacred Heart Hospital

研究点 (1)

Loading locations...

相似试验